Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.
Shao M, Miao M, Zhang X, Zhang X, An Y, Guo H, Lei L, Zhao Q, Ding Y, Lin J, Wu R, Yu F, Li Y, Miao H, Zhang L, Du Y, Jiao R, Pang L, Long L, Yao X, Shi X, Wang F, Cui L, Zhang L, Liu S, Lu F, Luo K, Zhao S, Wang Y, Wu X, Wang Q, Liu H, Song S, Zhou X, Zhang X, Shi S, Zhu H, Chen Y, Yu H, Wu J, Yu R, Fan W, Liu S, Xu J, Chen Z, Shi L, He J, Zhang X, Li Z, Li R.
Shao M, et al. Among authors: wu x, wu r, wu j.
Lupus Sci Med. 2022 Nov;9(1):e000779. doi: 10.1136/lupus-2022-000779.
Lupus Sci Med. 2022.
PMID: 36351697
Free PMC article.